Skip to main content

Blueprint for Access to Innovative Healthcare Episode 2: Screening

By: 3BL Media
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

SOURCE: Takeda

DESCRIPTION:

Takeda’s flagship Access to Medicines initiative, the Blueprint for Innovative Healthcare Access program, works with a consortium of public and private partners sharing resources and responsibility, each bringing specific strengths and expertise to address rising Non-Communicable Diseases (NCDs) challenges in underserved communities. Meet the people who are living and breathing the Blueprint in the second episode focusing on the importance of screening of NCDs of a 5-part series of our pilot program in Meru County, Kenya.

Tweet me: Meet the people who are living and breathing @Takeda's Blueprint in the second episode focusing on the importance of screening of NCDs of a 5-part series of our pilot program in Meru County, Kenya. https://bit.ly/3w5qELy

KEYWORDS: takeda, Blueprint for Access to Innovative Healthcare, NYSE: TAK

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  257.99
-9.75 (-3.64%)
AAPL  348.75
-3.70 (-1.05%)
AMD  489.63
-40.51 (-7.64%)
BAC  48.46
-0.45 (-0.92%)
GOOG  272.06
-7.13 (-2.56%)
META  598.16
-18.22 (-2.96%)
MSFT  500.44
-7.85 (-1.54%)
NVDA  147.43
-3.53 (-2.34%)
ORCL  110.70
-3.19 (-2.80%)
TSLA  376.11
-7.62 (-1.98%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.